Multiparameter Monitors in Georgia

Strados Labs is a respiratory-focused clinical trial solutions company delivering regulatory-grade endpoint data for pharmaceutical and biotech sponsors through Phase I–IV trials across 34 countries. The company specializes in continuous, ambulatory respiratory monitoring combined with AI-driven analysis and expert human review to capture disease burden between clinic visits. Product offerings include the Air Next Spirometer (FDA-cleared spirometry with FEV₁, FVC, FEV₁/FVC measurement), RESP® Biosensor (FDA 510(k)-cleared wearable capturing high-fidelity cough, lung sounds, vitals, and activity), RESP® Watch (clinical-trial-ready cough and activity monitoring), NObreath® FeNO (point-of-care fractional exhaled nitric oxide for airway inflammation assessment), and eCOA software suite (ePRO, eClinRO, eObsRO for electronic patient-reported and clinician-reported outcomes). Strados recently acquired NuvoAir's clinical trial business to expand its integrated endpoint platform. All devices are FDA 510(k) cleared, CE-marked, and ISO 13485 certified. The company has accumulated 87,000+ hours of respiratory data across 55+ clinical studies and published 70+ peer-reviewed papers in respiratory research journals including ERJ, CHEST, and npj Digital Medicine. Services include study design consultation, site support, device logistics, and GCP-compliant data delivery. The company serves pharma sponsors and contract research organizations seeking single-vendor respiratory endpoint solutions with retained audio, AI detection paired with expert review, and full audit trails for regulatory submission.

Mespere LifeSciences Inc. is a medical device innovator specializing in non-invasive, integrated hemodynamic monitoring solutions for cardiac and cerebral applications. The company develops advanced technologies for continuous, noninvasive monitoring of cardiac and neurological parameters, enabling real-time assessment of patient perfusion and hemodynamic status. Their product portfolio includes the Perfusion M system, designed to provide clinicians with integrated cardiac and cerebral monitoring capabilities without invasive procedures. Mespere's solutions are positioned for use in acute care, critical care, and perioperative settings where hemodynamic monitoring is essential for patient management and clinical decision-making. The company focuses on technology innovation in the patient monitoring segment, with emphasis on noninvasive methodologies that reduce procedural risk and improve patient comfort while maintaining clinical accuracy. Regulatory status and specific product certifications were not evident in the available content.

Rosie Connectivity Solutions is a long-term post-acute care (LTPAC) focused medical equipment and software provider founded in 1977. The company specializes in connected vitals monitoring systems and EHR integration solutions designed to reduce documentation errors, improve nursing workflow efficiency, and enhance patient outcomes in skilled nursing facilities and long-term care environments. Core offerings include the RosieConnectivity platform—a real-time data capture and documentation system that integrates vital signs directly into EHR workflows—and a suite of connected medical devices for point-of-care assessment and monitoring. The company serves skilled nursing facilities, assisted living, and post-acute care providers navigating Medicare/Medicaid reimbursement, infection control requirements, and labor cost pressures. Rosie's product ecosystem addresses common LTPAC pain points: reducing readmissions through continuous vitals monitoring, streamlining compliance documentation, and enabling remote patient assessment capabilities. The platform emphasizes seamless EHR integration to minimize manual data entry and clinical transcription errors. While specific regulatory certifications (FDA 510(k), ISO 13485) are not explicitly stated on the fetched content, the company's focus on connected medical devices and software systems for regulated healthcare environments suggests FDA oversight.

WEINMANN Emergency Medical Technology GmbH is a global specialist in emergency and prehospital medical devices, headquartered in Germany with five manufacturing sites worldwide. The company manufactures a comprehensive range of emergency ventilation equipment, patient monitoring and defibrillation systems, portable suction devices, oxygen delivery systems, data management solutions, and mobile transport solutions. Primary product lines include emergency and transport ventilators (notably the MEDUVENT Standard, a turbine-driven portable ventilator requiring no external oxygen supply), multiparameter patient monitors, defibrillators, and integrated emergency care systems. WEINMANN ventilators are deployed in more than 150 countries with approximately 90,000 units in active use globally. The company serves prehospital emergency medical services, air ambulance operators, hospitals, and military medical units. Products support mechanical ventilation during resuscitation, long-distance patient transport, and data capture for emergency response documentation. The company operates 350 employees and maintains an active research and development pipeline, including emerging products such as the MEDUVISION video laryngoscope announced for future release. Manufacturing capabilities include design, regulatory compliance, and global distribution. While specific certifications are not detailed on the homepage, the company operates under strict medical device regulations across multiple markets. WEINMANN emphasizes reliability, portability, and operational independence in emergency settings.

Shenzhen Homed Medical Device Co., Ltd, founded in 2003, is a manufacturer of home respiratory care and family health monitoring devices. The company specializes in oxygen therapy systems, nebulizers, nasal wash systems, portable suction units, and respiratory chronic disease management solutions. HOMED operates a Class 100,000 clean workshop compliant with GMPC standards and maintains production processes aligned with medical device quality management systems (ISO 13485). The company manufactures and supplies products for globally recognized OEM partners including AstraZeneca, Drive DeVilbiss, Incoterm, Sunset, and Compass Health. Core product lines include compressor nebulizers, mesh nebulizers, oxygen concentrators, aerosol therapy accessories, MDI spacers, and comprehensive respiratory care equipment. The company serves home healthcare providers, respiratory specialists, and chronic disease management programs across international markets. Manufacturing capabilities include sophisticated production equipment, complete inspection systems, and non-dusting rooms designed to pharmaceutical standards.